
New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations
Author(s) -
Thibaut Davy-Méndez,
Joseph J. Eron,
Laurence Brunet,
Oksana Zakharova,
Ann M. Dennis,
Sonia Napravnik
Publication year - 2018
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000001990
Subject(s) - antiretroviral drug , human immunodeficiency virus (hiv) , hiv drug resistance , drug resistance , medicine , drug , antiretroviral agents , sida , lentivirus , antiretroviral therapy , virology , viral disease , viral load , pharmacology , biology , microbiology and biotechnology
To estimate the prevalence of HIV drug resistance over time and identify risk factors for multiclass resistance.